Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score ® Test REDWOOD CITY, Calif., United States, and MECHELEN, Belgium, ...
A urological "smell" test for prostate cancer is snaking its way through the R&D process. The University of the West of England's Urological Institute team at Southmead Hospital and the Bristol Royal ...
Investigational assay detects the fusion of two genes that occurs in about half of prostate cancers. ORLANDO—A urine test may enable clinicians to predict which men diagnosed with prostate cancer are ...
PSA blood test IsoPSA can correctly rule out high-grade prostate cancer 93% of the time and thus has the potential to reduce the number of unnecessary prostate biopsies. The following article is part ...
A urological "smell" test for prostate cancer is snaking its way through the R&D process. The University of the West of England's Urological Institute team at Southmead Hospital and the Bristol Royal ...
CHATSWORTH, Calif., May 23, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), announced today that a poster of the results of a multi-center clinical study utilizing its proprietary ...
PRESS RELEASE: 3 December 2018, 22:30 CET/16:30 EST Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score ® Test REDWOOD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback